Rockwell Medical, Inc.
RMTI
$0.69
$0.033.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -189.71% | 68.40% | -17.49% | 1.52% | -100.40% |
| Total Depreciation and Amortization | -6.41% | 0.37% | -3.37% | 4.45% | -0.74% |
| Total Amortization of Deferred Charges | -1.12% | 0.00% | 1.14% | 0.00% | -1.12% |
| Total Other Non-Cash Items | 34.66% | -14.40% | 1.79% | -21.51% | 15.75% |
| Change in Net Operating Assets | -114.68% | 230.45% | -161.25% | 147.91% | -74,860.00% |
| Cash from Operations | -107.29% | 275.29% | -170.88% | 152.88% | -503.12% |
| Capital Expenditure | -394.19% | 62.45% | -39.63% | -160.32% | 84.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.16% | 0.86% | -6,788.52% | -1.61% | -1.59% |
| Cash from Investing | 97.05% | 4.13% | -4,083.50% | -10,200.00% | 99.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.29% | 4.04% | -49.77% | 38.04% | -1.17% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.33% | 0.00% | -72.41% | 0.23% | 33.23% |
| Cash from Financing | 23.23% | -115.70% | 1,137.54% | 16.99% | -128.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.99% | -357.00% | 3.39% | 125.54% | -228.49% |